EX-10.1
from 8-K
133 pages
Note Purchase Agreement Dated as of October 1, 2021 Among Osmotica Pharmaceutical Corp., as the Issuer, Osmotica Holdings US LLC, as Intermediate Holdings, Osmotica Pharmaceuticals Plc, as Super Holdings, Certain Subsidiaries of Super Holdings, as the Guarantors, Athyrium Opportunities IV Acquisition LP, as the Administrative Agent and the Purchasers From Time to Time Party Hereto
12/34/56